Yves Rinaldi
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 19
- Pancreatic and Hepatic Oncology Research 17
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Screening and Detection 6
- Geriatrics and Gerontology top 10%
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- Cancer Genomics and Diagnostics 13
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Treatments and Mutations 6
In The Last Decade
Yves Rinaldi
41 papers receiving 403 citations
Peers
Comparison fields: 5 of 52
- Oncology 343
- Geriatrics and Gerontology 36
- Hepatology 55
- Cancer Research 98
- Pulmonary and Respiratory Medicine 132
Countries citing papers authored by Yves Rinaldi
This map shows the geographic impact of Yves Rinaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Rinaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Rinaldi more than expected).
Fields of papers citing papers by Yves Rinaldi
This network shows the impact of papers produced by Yves Rinaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Rinaldi. The network helps show where Yves Rinaldi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yves Rinaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 45 | |
| 9 | 2020 | 11 | |
| 10 | Cholangitis Due to Pancreaticobiliary Fistula and Intraductal Papillary Mucinous Neoplasm: Thick Mucus Alters the Effectiveness of BiliaryDrainage | 2018 | 0 |
| 11 | 2018 | 3 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 50 | |
| 14 | 2016 | 3 | |
| 15 | 2016 | 1 | |
| 16 | 2015 | 6 | |
| 17 | 2014 | 9 | |
| 18 | 2013 | 4 | |
| 19 | 2010 | 15 | |
| 20 | 2007 | 12 |
About Yves Rinaldi
Yves Rinaldi is a scholar working on Oncology, Cancer Research and Hepatology, having authored 47 papers that have together received 410 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Pancreatic and Hepatic Oncology Research (17 papers), Cancer Treatment and Pharmacology (14 papers), Cancer Genomics and Diagnostics (13 papers), Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Screening and Detection (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (343 citations), Geriatrics and Gerontology (36 citations) and Hepatology (55 citations). Yves Rinaldi has collaborated with scholars based in France, Austria and Canada. Frequent co-authors include Thomas Aparicio, F. Rétornaz, Laëtitia Dahan, Éric François, Karine Le Malicot, Jean‐Baptiste Bachet, Jean–Marc Phelip, Julien Taı̈eb, Olivier Bouché and Christophe Louvet. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, British Journal of Cancer and European Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.